Laboratory of Cytogenetics, Molecular Genetics and Biology of Human Reproduction, University Hospital Farhat Hached, Sousse, Tunisia; Faculty of Medicine of Sousse, University of Sousse.
Faculty of Medicine of Sousse, University of Sousse; Gastroenterology Department, University Hospital Farhat Hached, Sousse, Tunisia.
Arab J Gastroenterol. 2022 Aug;23(3):210-217. doi: 10.1016/j.ajg.2022.06.002. Epub 2022 Jul 31.
Low phospholipid-associated cholelithiasis (LPAC) syndrome is a form of cholelithiasis associated with the ABCB4 gene mutation. The defects of the protein ABCB4 encoded by this gene promote the formation of biliary cholesterol microcalculations. ABCB4 screening is negative in a significant proportion of patients.
An analytical study of the epidemiological, clinical, biological, and radiological characteristics of 19 patients was conducted, followed by Sanger-type sequencing of the 27 exons encoding the ABCB4 gene.
Our results showed a female predominance, symptomatic vesicular lithiasis predominance, and a high frequency of biliary complications in patients carrying an ABCB4 mutation. Normal liver enzyme values were found in 84.2% of the cases. Intrahepatic hyperechoic foci were present in 68.4%. Molecular analysis detected a pathogenic mutation of the ABCB4 gene in 31.57% of patients. The mutations found were a nonsense mutation and three missense mutations, including two new mutations.
Our epidemiological, clinical, and genetic results concord with previous studies of LPAC syndrome. Two of the mutations we found have never been detected in patients with LPAC. The low percentage of ABCB4 gene mutations can be explained by the absence of studies of other genes involved in bile acid homeostasis besides the ABCB4 gene and by the inclusion criteria used in this study.
低磷脂酰胆碱相关胆石症(LPAC)综合征是一种与 ABCB4 基因突变相关的胆石症。该基因编码的蛋白 ABCB4 的缺陷促进了胆汁胆固醇微结晶的形成。该基因的 ABCB4 筛查在很大一部分患者中呈阴性。
对 19 名患者的流行病学、临床、生物学和放射学特征进行了分析性研究,然后对编码 ABCB4 基因的 27 个外显子进行 Sanger 型测序。
我们的结果显示,女性患者居多,症状性胆囊结石为主,携带 ABCB4 突变的患者胆道并发症发生率较高。84.2%的病例肝酶值正常。68.4%的病例存在肝内高回声灶。分子分析在 31.57%的患者中检测到 ABCB4 基因的致病性突变。发现的突变包括一个无义突变和三个错义突变,其中包括两个新突变。
我们的流行病学、临床和遗传结果与 LPAC 综合征的先前研究一致。我们发现的两种突变从未在 LPAC 患者中检测到。除了 ABCB4 基因外,其他参与胆汁酸稳态的基因的研究以及本研究中使用的纳入标准可以解释 ABCB4 基因突变的低百分比。